X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (12) 12
oncology (12) 12
index medicus (9) 9
female (8) 8
aged (7) 7
middle aged (7) 7
chemotherapy (6) 6
adult (5) 5
male (4) 4
survival (4) 4
aged, 80 and over (3) 3
breast neoplasms - diagnostic imaging (3) 3
cancer (3) 3
colorectal cancer (3) 3
fluorouracil (3) 3
leucovorin (3) 3
predictive value of tests (3) 3
surgery (3) 3
therapy (3) 3
angiogenesis inhibitors - adverse effects (2) 2
angiogenesis inhibitors - therapeutic use (2) 2
antimitotic agents (2) 2
antineoplastic agents (2) 2
antineoplastic combined chemotherapy protocols - therapeutic use (2) 2
bevacizumab (2) 2
breast cancer (2) 2
breast neoplasms - drug therapy (2) 2
breast neoplasms - pathology (2) 2
breast neoplasms - surgery (2) 2
carcinoma (2) 2
carcinoma, renal cell - drug therapy (2) 2
care and treatment (2) 2
cell migration (2) 2
chemotherapy, adjuvant (2) 2
colorectal neoplasms - drug therapy (2) 2
disease-free survival (2) 2
everolimus (2) 2
expression (2) 2
head and neck cancer (2) 2
hematology (2) 2
hematology, oncology and palliative medicine (2) 2
immunohistochemistry (2) 2
incidence (2) 2
kaplan-meier estimate (2) 2
kidney neoplasms - drug therapy (2) 2
neoplasms - drug therapy (2) 2
neoplasms. tumors. oncology. including cancer and carcinogens (2) 2
otorhinolaryngology (2) 2
protein-tyrosine kinases - antagonists & inhibitors (2) 2
radionuclide imaging (2) 2
radiotherapy (2) 2
randomized phase-ii (2) 2
ras mutations (2) 2
renal cell carcinoma (2) 2
retrospective studies (2) 2
risk (2) 2
risk assessment (2) 2
scintimammography (2) 2
sensitivity and specificity (2) 2
sirolimus - analogs & derivatives (2) 2
sorafenib (2) 2
squamous-cell carcinoma (2) 2
sunitinib (2) 2
technetium tc 99m sestamibi (2) 2
tor serine-threonine kinases - antagonists & inhibitors (2) 2
trial (2) 2
tumors (2) 2
1st-line treatment (1) 1
abnormal expression (1) 1
actin (1) 1
actin cytoskeleton (1) 1
actins - metabolism (1) 1
adenocarcinoma - drug therapy (1) 1
adenocarcinoma - metabolism (1) 1
adenoid cystic carcinoma (1) 1
adolescent (1) 1
age factors (1) 1
akt (1) 1
alanine transaminase - blood (1) 1
analogs (1) 1
analysis (1) 1
androgen receptor (1) 1
angiogenesis inhibitors - administration & dosage (1) 1
antibiotics, antineoplastic - therapeutic use (1) 1
antibodies, monoclonal, humanized - therapeutic use (1) 1
antimetabolites, antineoplastic - adverse effects (1) 1
antimetabolites, antineoplastic - pharmacokinetics (1) 1
antimetabolites, antineoplastic - therapeutic use (1) 1
antineoplastic agents - administration & dosage (1) 1
antineoplastic agents - adverse effects (1) 1
antineoplastic agents - therapeutic use (1) 1
antineoplastic combined chemotherapy protocols - adverse effects (1) 1
aspartate aminotransferases - blood (1) 1
aurora (1) 1
aurora-a activation (1) 1
axillary lymph-nodes (1) 1
axitinib (1) 1
basal-like (1) 1
beta catenin - metabolism (1) 1
beta-catenin (1) 1
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Lancet Oncology, The, ISSN 1470-2045, 2015, Volume 16, Issue 13, pp. 1306 - 1315
Summary Background In the TRIBE study, FOLFOXIRI (fluorouracil, leucovorin, oxaliplatin, and irinotecan) plus bevacizumab significantly improved... 
Hematology, Oncology and Palliative Medicine | TRIAL | CETUXIMAB | SURROGATE | LEUCOVORIN | ONCOLOGY | END-POINT | PROGRESSION-FREE SURVIVAL | RAS MUTATIONS | GUIDELINES | KRAS | FLUOROURACIL | Leucovorin - administration & dosage | ras Proteins - genetics | Proto-Oncogene Proteins p21(ras) | Bevacizumab - therapeutic use | Bevacizumab - adverse effects | Colorectal Neoplasms - genetics | Humans | Middle Aged | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Male | Angiogenesis Inhibitors - administration & dosage | Neoplasm Metastasis | Organoplatinum Compounds - administration & dosage | Fluorouracil - administration & dosage | Time Factors | DNA Mutational Analysis | Colorectal Neoplasms - drug therapy | Angiogenesis Inhibitors - therapeutic use | Camptothecin - administration & dosage | Female | Angiogenesis Inhibitors - adverse effects | Camptothecin - analogs & derivatives | Colorectal Neoplasms - mortality | Bevacizumab - administration & dosage | Drug Administration Schedule | Kaplan-Meier Estimate | Proportional Hazards Models | Proto-Oncogene Proteins - genetics | Treatment Outcome | Disease-Free Survival | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Proto-Oncogene Proteins B-raf - genetics | Intention to Treat Analysis | Italy | Aged | Infusions, Intravenous | Mutation | Colorectal Neoplasms - pathology | Antimitotic agents | Cancer patients | Care and treatment | Patient outcomes | Analysis | Colorectal cancer | Leucovorin | Metastasis | Antineoplastic agents
Journal Article
Head & Neck, ISSN 1043-3074, 09/2017, Volume 39, Issue 9, pp. 1806 - 1818
Journal Article
International Journal of Oncology, ISSN 1019-6439, 12/2012, Volume 41, Issue 6, pp. 2128 - 2138
Journal Article
American Journal of Clinical Oncology: Cancer Clinical Trials, ISSN 0277-3732, 12/2014, Volume 37, Issue 6, pp. 611 - 615
Journal Article
Journal of Translational Medicine, ISSN 1479-5876, 01/2015, Volume 13, Issue Suppl 1, pp. 1 - 2
Journal Article
Critical Reviews in Oncology / Hematology, ISSN 1040-8428, 12/2017, Volume 120, pp. 93 - 97
•Salivary gland malignant tumor (SGMT) represents a rare entity.•Multidisciplinary approach, as well as management in a specialist centre are paramount.•This... 
Parotid | Chemotherapy | Surgery | Salivary gland | Head and neck cancer | Management | Radiotherapy | Outcomes | SURVIVAL | ONCOLOGY | ADENOID CYSTIC CARCINOMA | HEMATOLOGY
Journal Article
Critical Reviews in Oncology and Hematology, ISSN 1040-8428, 2017, Volume 113, pp. 151 - 155
Highlights • Risk of local and distant recurrences is high in head and neck cancer (HNC). • The role of adequate follow-up program in HNC is paramount. •... 
Hematology, Oncology and Palliative Medicine | Head and neck cancer | Chemotherapy | Radiotherapy | Surgery | Follow-up | MELANOMA | ONCOLOGY | SQUAMOUS-CELL CARCINOMA | ORAL-CAVITY | LARYNX | HEMATOLOGY | CARE | Disease Management | Follow-Up Studies | Humans | Head and Neck Neoplasms - therapy
Journal Article
Journal of Medical Case Reports, ISSN 1752-1947, 2011, Volume 5, Issue 1, pp. 334 - 334
Primary gallbladder neuroendocrine tumors are extremely rare, representing 0.2% of all neuroendocrine tumors. The diagnosis is incidental in most cases. We... 
Immunohistochemistry | Usage | Ultrasonic waves
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 05/2016, Volume 34, Issue 15_suppl, pp. e15007 - e15007
Journal Article
Journal Article
Journal Article
No results were found for your search.

Cannot display more than 1000 results, please narrow the terms of your search.